Admission Date:  [**2114-9-6**]     Discharge Date:  [**2114-9-10**]

Date of Birth:   [**2049-7-21**]     Sex:  M

Service:  MEDICINE

HISTORY OF PRESENT ILLNESS:  This is a 65 year-old male with
a past medical history of severe chronic obstructive
pulmonary disease and baseline O2 requirement at home who was
rushing this a.m. for an early morning pulmonary clinic
appointment, felt short of breath and used 2 liters of oxygen
portable in car without relief.  In arrival to the office
with continued shortness of breath.  He denies cough or
sputum at that time.  He denies fevers or chills.  No chest
pain.  No recent illnesses.  He denies other symptoms.  No
nausea, vomiting, bowel movement changes, no constipation.
No change in urinary habits or no urinary symptoms.  No
change in appetite.  No lower extremity edema.  No recent
upper respiratory infection.  No orthopnea.  No change in
shortness of breath greater then baseline until [**9-6**].  No
paroxysmal nocturnal dyspnea.  The patient was evaluated by
Dr. [**Last Name (STitle) **] in the Pulmonary Clinic who felt the patient
would benefit from biPAP.

Vital signs, pulse 94.  Blood pressure 129/74.  Respiratory
rate 23.  Pulse ox 97% on 2 liters.  Arterial blood gases
revealed 7.31/702/67.  There was no baseline available in the
last 100 days.  In the Emergency Department the patient
received Levofloxacin 500 mg po, Xanax, Solu-Medrol 125 mg
IV, Albuterol nebulizers.  Chest x-ray at the time showed
hyperinflated lungs bilaterally.  Electrocardiogram was
normal sinus rhythm at a ventricular response rate of 95,
normal axis, normal intervals.  No ST T changes.

PAST MEDICAL HISTORY:  1.  Chronic obstructive pulmonary
disease, FEV1 .4, FEV1 of FVC of 36%, FVC of 40%.  2.
Anxiety.  3.  Twenty pound weight loss for the past one year.

ALLERGIES:  No known drug allergies.

MEDICATIONS AS AN OUTPATIENT:  Albuterol MDI two puffs
q.i.d., Atrovent MDI two puffs q.i.d., Albuterol nebulizers
two q.i.d., Serevent two puffs q.i.d., Claritin 10 mg po
q.d., Xanax 1 mg po q.i.d.

SOCIAL HISTORY:  Lives at daughters home.  [**Name2 (NI) **] alcohol.  No
drugs.  Current smoker, two to three cigarettes per day, two
packs per day times fifty years previously.

FAMILY HISTORY:  Stomach CA.

PHYSICAL EXAMINATION ON ADMISSION:  Vital signs, pulse 94.
Blood pressure 129/72.  Pulse ox 67% on 2 liters nasal
cannula.  Respiratory rate 16.  General, this is an older
then stated age male, fatigued breathing with pursed lips
bending over bed.  Oropharynx clear.  Face without erythema.
Neck was supple.  No lymphadenopathy.  Accessory muscles
being used.  No JVD.  Lungs distant breath sounds, coarse
rhonchi, scattered.  Poor air movement.  Positive barrel
chest appearance.  Cardiac regular rate and rhythm.  S1 and
S2.  No murmurs, rubs or gallops.  Distant heart sounds.
Abdomen was soft, nontender, nondistended.  Positive bowel
sounds.  Positive paradoxical movement.  Extremities, no
clubbing, cyanosis or edema.  Neurological 5 out of 5
strength bilateral upper extremity and lower extremity.

LABORATORY ON ADMISSION:  White count 9.9, hematocrit 45.7,
platelets 285, 70 neutrophils, 23 lymphocytes, 5 monocytes, 2
eosinophils.  Sodium 140, K 4.8, chloride 98, CO2 34, BUN 7,
creatinine .7, glucose 101.  Arterial blood gases revealed
7.31/38/72.  Chest x-ray marked emphysema.  No pneumonia.
Pulmonary function tests [**2-18**] severe obstructive defect
probably gas trapping, FEV1 15% predicted, FEV1/FVC 36%, PVC
40% predicted.

HOSPITAL COURSE:  1.  Chronic obstructive pulmonary disease:
The patient was transitioned from Solu-Medrol 125 mg
intravenous q.d. to the next day 60 mg po Prednisone q.d.
The patient was continued on Levofloxacin 500 mg q.d.  the
patient has no history of cardiac disease and was not thought
that cardiac disease attributed to acute chronic obstructive
pulmonary disease exacerbation.  The patient was put on BIPAP
on the night of [**9-7**] and continued throughout his hospital
stay to use BIPAP.  The patient was sent home on BIPAP.  The
patient noticed improvement in breathing ability after
nightly BIPAP treatment.  The patient was treated with
Albuterol and Atrovent nebulizers q 4 hours as well as
Serevent.  The patient was discharged home on a steroid taper
of twenty days, home O2 BIPAP to be used at night,
Levofloxacin to finish a fourteen day course as well as
Albuterol and Atrovent nebulizers.  The patient did complain
of mild runny nose at the time of discharge.  This was
treated with Flonase and nasal inhaler as well as continuing
Claritin q.d.

2.  Anxiety:  The patient exhibited occasional symptoms of
anxiousness.  The patient was continued on Xanax 1 mg po
q.i.d. as well as Serax 15 mg po q.h.s.  This appeared to
satisfy the patient's anxiety needs.

DISCHARGE CONDITION:  Fair.

DISCHARGE STATUS:  No change in discharge status.  The
patient is full code.

DISCHARGE DIAGNOSES:
1.  Chronic obstructive pulmonary disease, severe.
2.  Anxiety disorder.

DISCHARGE MEDICATIONS:  1.  Prednisone 60 mg to complete a
twenty day taper.  2.  Levofloxacin 500 mg po q.d. to
complete a fourteen day course.  3.  Albuterol MDI two puffs
q.i.d.  4.  Atrovent MDI two puffs q.i.d.  5.  Claritin 10 mg
po q.d.  6.  Xanax 1 mg po q.i.d.  7.  Serax 15 mg po q.h.s.
prn.  8.  BIPAP at night.  9.  Home O2 as needed.  10.
Flonase two puffs inhaled through each nostril q.d.

FOLLOW UP:  The patient is to follow up with Dr. [**Last Name (STitle) **] in
the Pulmonary Clinic.





                          [**First Name11 (Name Pattern1) **] [**Initial (NamePattern1) **] [**Last Name (NamePattern1) **], M.D.  [**MD Number(1) 103528**]

Dictated By:[**Last Name (NamePattern1) 1324**]

MEDQUIST36

D:  [**2114-9-10**]  15:44
T:  [**2114-9-11**]  11:03
JOB#:  [**Job Number **]
